Literature DB >> 20851723

Taming PRRSV: revisiting the control strategies and vaccine design.

Roongroje Thanawongnuwech1, Sanipa Suradhat.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) continues to be a threat, causing economically significant impacts on the swine industry worldwide. In this article, we share the information related to the Thai PRRSV and review the available options for PRRS control strategies. Unfortunately, the traditional control strategies and conventional vaccines fail to provide sustainable disease control, as they suffer from both antigenic heterogeneity and various immune evasion strategies of PRRSV. Induction of interleukin (IL)-10 following PRRSV infection is believed to be a focal mechanism leading to the unique immunological outcomes and interference of PRRS vaccine efficacy. It is likely that the nucleocapsid protein plays an important role in induction of IL-10 following PRRSV infection. We propose that removal or reduction of the PRRSV-induced, negative immunomodulatory effects especially during the first 2 weeks following infection is essential to establish proper anti-PRRSV immunity. In other word, incorporation of the "taming strategy" will be needed to reduce PRRSV-induced immunomodulatory effects, and to ensure maximal vaccine-induced immunity in the face of viral exposure. Any PRRSV vaccine that can induce cross-protective immunity and simultaneously eliminate the immunoinhibitory effects of PRRSV would be ideal. In addition, tracking of the inhibitory parameters, following the PRRSV challenge should be included in the vaccine testing protocol. Therefore, the future of PRRSV vaccine development relies tremendously on the basic knowledge of host-virus interactions and the communication between the basic and clinical PRRSV research fields.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20851723     DOI: 10.1016/j.virusres.2010.09.003

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  33 in total

1.  Development of a chimeric strain of porcine reproductive and respiratory syndrome virus with an infectious clone and a Korean dominant field strain.

Authors:  Jung-Ah Lee; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  J Microbiol       Date:  2014-03-29       Impact factor: 3.422

2.  Seroprevalence of porcine reproductive and respiratory syndrome, Aujeszky's disease, and porcine parvovirus in replacement gilts in Thailand.

Authors:  Padet Tummaruk; Rachod Tantilertcharoen
Journal:  Trop Anim Health Prod       Date:  2011-11-09       Impact factor: 1.559

Review 3.  Porcine reproductive and respiratory syndrome virus vaccines: Immunogenicity, efficacy and safety aspects.

Authors:  Wasin Charerntantanakul
Journal:  World J Virol       Date:  2012-02-12

4.  Reproductive performance of sows with and without PRRS modified live virus vaccination in PRRS-virus-seropositive herds.

Authors:  Em-On Olanratmanee; Roongroje Thanawongnuwech; Annop Kunavongkrit; Padet Tummaruk
Journal:  Trop Anim Health Prod       Date:  2014-05-10       Impact factor: 1.559

5.  Knockdown expression of IL-10Rα gene inhibits PRRSV replication and elevates immune responses in PBMCs of Tibetan pig in vitro.

Authors:  Yihui Chen; Ye Wang; Kai Zeng; Yun-Feng Lei; Xiao-Hui Chen; San-Cheng Ying; Xue-Bin Lv; Zezhou Wang; Rong Gao
Journal:  Vet Res Commun       Date:  2017-12-08       Impact factor: 2.459

6.  Host inhibits replication of European porcine reproductive and respiratory syndrome virus in macrophages by altering differential regulation of type-I interferon transcriptional response.

Authors:  Tahar Ait-Ali; Alison D Wilson; Wilfrid Carré; David G Westcott; Jean-Pierre Frossard; Marnie A Mellencamp; Daphne Mouzaki; Oswald Matika; David Waddington; Trevor W Drew; Stephen C Bishop; Alan L Archibald
Journal:  Immunogenetics       Date:  2011-03-05       Impact factor: 2.846

7.  Porcine reproductive and respiratory syndrome virus detection in Thailand during 2005-2010 in relation to clinical problems, pig types, regions, and seasons.

Authors:  Padet Tummaruk; Pannin Surapat; Sutharat Sriariyakun; Oraphan Seemakram; Em-on Olanratmanee; Rachod Tantilertcharoen; Roongroj Thanawongnuwech
Journal:  Trop Anim Health Prod       Date:  2012-10-13       Impact factor: 1.559

8.  Peptide nanofiber hydrogel adjuvanted live virus vaccine enhances cross-protective immunity to porcine reproductive and respiratory syndrome virus.

Authors:  Xiangdong Li; Amy Galliher-Beckley; Hongzhou Huang; Xiuzhi Sun; Jishu Shi
Journal:  Vaccine       Date:  2013-08-09       Impact factor: 3.641

9.  The 15N and 46R Residues of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Nucleocapsid Protein Enhance Regulatory T Lymphocytes Proliferation.

Authors:  Baochao Fan; Xing Liu; Juan Bai; Yufeng Li; Qiaoya Zhang; Ping Jiang
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

10.  Comparison of the efficacy of autogenous inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccines with that of commercial vaccines against homologous and heterologous challenges.

Authors:  Marc F Geldhof; Merijn Vanhee; Wander Van Breedam; Jan Van Doorsselaere; Uladzimir U Karniychuk; Hans J Nauwynck
Journal:  BMC Vet Res       Date:  2012-10-03       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.